Believes Years of Self-Inflicted Issues Have Caused Avantor to Trade at a Meaningful Discount to its Intrinsic Value and Life Sciences Peers Contends the Board Has Failed to Remedy Operating Underperformance, Ineffective Cost Controls and Poor Capital Deployment – Resulting in Significant Value Destruction Over Every Relevant Period Makes Clear the Board Needs to Be […]
Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today issued the following statement in response to the […]
Strengthens 90-year legacy of partnership between MilliporeSigma and WashU to accelerate scientific progress Strategic academic-industry alliance aims to build robust Research & Development talent pipeline Reinforces Mill ST. LOUIS — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a non-binding Memorandum of […]
BURLINGAME, Calif. — Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, and deepmirror, the AI drug design platform that empowers chemists to focus on more promising drug molecules, today announced a strategic partnership integrating deepmirror with CDD Vault to enhance drug discovery. CDD Vault helps research teams […]
Cambridge UK – Cresset, a leading provider of innovative solutions for the digitization of drug discovery, announces the acquisition of Molab.ai, a pioneer in artificial intelligence technologies tailored for molecular research. This strategic acquisition will combine Cresset’s powerful computational chemistry platform with Molab.ai’s proven capability to build highly predictive ADME models. It marks a significant […]
Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth
Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK businesses on high […]
The research will focus on developing faster and more accurate methods for predicting drug metabolism CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project […]
INNOptimizer is using latest Bayesian Optimization algorithms and a broad set of analytical tools to guide optimizations with minimum experimentation needed. Don’t waste time and money with poor experimental design – use INNOptimizer™ to guide your experiments with state-of-the art Bayesian Optimization algorythms.”— Oliver May (GM Synsilico)GELEEN, LIMBURG, NETHERLANDS, July 2, 2025 /EINPresswire.com/ — SynSilico, […]
Mumbai, India – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and a wholly owned subsidiary of PI Industries, today announced a strategic collaboration with Cresset® to implement Torx® Software, a state-of-the-art cloud-based platform for small molecule drug discovery. This partnership marks a significant step in PI Health Sciences’ […]
Paris – Iktos, a leading provider of artificial intelligence solutions for drug discovery, is pleased to announce it has become an Advanced Technology Partner in the AWS Partner Network and joined the AWS ISV (Independent Software Vendor) Accelerate co-sell program. As part of this collaboration, Iktos has made Makya, its innovative de novo drug design […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
